There was a trend towards reduced median hepcidin-25 levels in participants with polycystic ovary syndrome ( n = 27) compared with weight-matched control subjects ( n = 16); however, this did not reach statistical significance.
1
—
—
There was a trend towards reduced median hepcidin-25 levels in participants with polycystic ovary syndrome ( n = 27) compared with weight-matched control subjects ( n = 16); however, this did not reach statistical significance.